These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6996259)

  • 1. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens.
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Acta Med Scand; 1980; 208(1-2):49-54. PubMed ID: 7435247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
    Löllgen H; Schmidt A; Upmeyer HJ
    Med Klin (Munich); 1986 Nov; 81(23):745-50. PubMed ID: 2880283
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative double-blind, crossover and randomized study of the antihypertensive activity of nifedipine in primary arterial hypertension].
    de Mendonça JV; de Castro Filho J
    Arq Bras Cardiol; 1984 Sep; 43(3):219-22. PubMed ID: 6398995
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of long-acting propranolol and conventional metoprolol in the treatment of hypertension.
    Jäättelä A; Mäki O
    Ann Clin Res; 1983 Apr; 15(2):45-9. PubMed ID: 6349512
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.
    Lins LE; Berglund J; Eliasson K; Wernersson B
    Clin Ther; 1983; 5(3):251-9. PubMed ID: 6850719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Slow-release hydralazine in the treatment of essential arterial hypertension].
    Moscovici H; Yasbeck Júnior P; Fadul Neto J
    Arq Bras Cardiol; 1982 Sep; 39(3):197-9. PubMed ID: 7186366
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting or conventional propanolol in hypertension?
    Woods JO
    Practitioner; 1979 Dec; 223(1338):834-7. PubMed ID: 396526
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of Inderex in the treatment of essential hypertension.
    Crowe PF; Finnegan OC; Russell CJ; Varma MP
    Br J Clin Pract; 1987 Oct; 41(10):967-70. PubMed ID: 3333146
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydralazine once daily in hypertension.
    Silas JH; Ramsay LE; Freestone S
    Br Med J (Clin Res Ed); 1982 May; 284(6329):1602-4. PubMed ID: 6805621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
    Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
    Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
    [No Abstract]   [Full Text] [Related]  

  • 15. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 16. Slow-release metoprolol, hydrochlorothiazide and hydralazine in stepwise treatment of essential hypertension.
    Houtzagers JJ; Dols DM; Meems L
    Neth J Med; 1984; 27(8):287-92. PubMed ID: 6504227
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
    Pape J
    Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
    [No Abstract]   [Full Text] [Related]  

  • 19. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
    Pape J
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1139-42. PubMed ID: 4584539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.